Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma-Reference-Cited by-同舟云学术

Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma

Published:2020-03-13 Issue:5 Volume:14 Page:991-1000
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Wang Haoyu¹²³⁴,Wang Zhaohui¹²³,Zhang Huiping¹²³,Qi Zeng¹²³^ORCID,Johnson Ariel C.¹,Mathes David¹,Pomfret Elizabeth A.²,Rubin Erin⁵,Huang Christene A.¹²³,Wang Zhirui¹²³^ORCID

Affiliation:

1. Division of Plastic and Reconstructive Surgery Department of Surgery School of Medicine University of Colorado Denver Aurora CO USA

2. Division of Transplant Surgery Department of Surgery School of Medicine University of Colorado Denver Aurora CO USA

3. Center for Transplantation Sciences Massachusetts General Hospital and Harvard Medical School Boston MA USA

4. College of Animal Science and Veterinary Medicine Shanxi Agricultural University Taigu China

5. Transplantation Pathology Department of Pathology School of Medicine University of Colorado Denver Aurora CO USA

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12653

Reference26 articles.

1. Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies

2. Systemic therapy of cutaneous T-cell lymphoma (CTCL)

3. Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents

4. Duration of Response in Cutaneous T-Cell Lymphoma Patients Treated With Denileukin Diftitox: Results From 3 Phase III Studies

5. Increased CCR4 Expression in Cutaneous T Cell Lymphoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Next top” mouse models advancing CTCL research;Frontiers in Cell and Developmental Biology;2024-04-10

2. Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs;European Journal of Pharmacology;2024-04

3. Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment;Experimental & Molecular Medicine;2023-09-01

4. CCR4‐IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T‐cell lymphoma in a mouse CTCL model;FEBS Open Bio;2023-05-15

5. Splice Variants of G Protein-Coupled Receptors Expressed in Cancers: Effective Targeting with Monoclonal Antibodies and Antibody-Like Scaffolds As Ligands Irrespective of the Pharmacological Status of Isoforms;Handbook of Cancer and Immunology;2022